Clinical Trial Update: SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)

View source ↗

Summary

The SNaP Wound Care System trial evaluating treatment over skin cancer excision sites and split-thickness skin grafts has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Snippet

Sponsor: Solventum US LLC | Conditions: Split Thickness Skin Graft, Skin Cancer Excision Site | Status: WITHDRAWN